Increased Expression of the Auxiliary β₂-subunit of Ventricular L-type Ca²⁺ Channels Leads to Single-Channel Activity Characteristic of Heart Failure

• Roger Hullin ,

  Contributed equally to this work with: Roger Hullin, Jan Matthes

  *To whom correspondence should be addressed. E-mail: roger.hullin@insel.ch (RH); stefan.herzig@uni-koeln.de (SH); schwara@email.uc.edu (AS)

  Affiliation Department of Cardiology, Swiss Heart Center Bern, University Hospital, Bern, Switzerland

  ⨯
• Jan Matthes ,

  Contributed equally to this work with: Roger Hullin, Jan Matthes

  Affiliation Department of Pharmacology, University of Cologne, Cologne, Germany

  ⨯
• Sibylle von Vietinghoff,

  Affiliations Department of Pharmacology, University of Wuerzburg, Wuerzburg, Germany, Franz Volhard Clinic, Nephrology/Hypertension Section, Medical Faculty of the Charité, Berlin, Germany

  ⨯
• Ilona Bodi,

  Affiliation University of Cincinnati College of Medicine, Institute of Molecular Pharmacology and Biophysics, University of Cincinnati, Cincinnati, Ohio, United States of America

  ⨯
• Marta Rubio,

  Affiliation University of Cincinnati College of Medicine, Institute of Molecular Pharmacology and Biophysics, University of Cincinnati, Cincinnati, Ohio, United States of America

  ⨯
• Karen D'Souza,

  Affiliation University of Cincinnati College of Medicine, Institute of Molecular Pharmacology and Biophysics, University of Cincinnati, Cincinnati, Ohio, United States of America

  ⨯
• Ismail Friedrich Khan,

  Affiliations Department of Pharmacology, University of Cologne, Cologne, Germany, Center of Molecular Medicine, University of Cologne, Cologne, Germany

  ⨯
• Dennis Rottländer,

  Affiliation Department of Pharmacology, University of Cologne, Cologne, Germany

  ⨯
• Uta C. Hoppe,

  Affiliation Center of Molecular Medicine, University of Cologne, Cologne, Germany

  ⨯
• Paul Mohacsi,

  Affiliation Department of Cardiology, Swiss Heart Center Bern, University Hospital, Bern, Switzerland

  ⨯
• Eva Schmitteckert,

  Affiliation Department of Pharmacology, University of Wuerzburg, Wuerzburg, Germany

  ⨯
• Ralf Gilsbach,

  Affiliation Department of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Freiburg, Germany

  ⨯
• Moritz Bünemann,

  Affiliation Department of Pharmacology, University of Wuerzburg, Wuerzburg, Germany

  ⨯
• Lutz Hein,

  Affiliations Department of Pharmacology, University of Wuerzburg, Wuerzburg, Germany, Department of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Freiburg, Germany

  ⨯
• Arnold Schwartz ,

  *To whom correspondence should be addressed. E-mail: roger.hullin@insel.ch (RH); stefan.herzig@uni-koeln.de (SH); schwara@email.uc.edu (AS)

  Affiliation University of Cincinnati College of Medicine, Institute of Molecular Pharmacology and Biophysics, University of Cincinnati, Cincinnati, Ohio, United States of America

  ⨯
•  [ ... ],
• Stefan Herzig

  *To whom correspondence should be addressed. E-mail: roger.hullin@insel.ch (RH); stefan.herzig@uni-koeln.de (SH); schwara@email.uc.edu (AS)

  Affiliations Department of Pharmacology, University of Cologne, Cologne, Germany, Center of Molecular Medicine, University of Cologne, Cologne, Germany

  ⨯
• [ view all ]
• [ view less ]